Nutrigenomics Market Size, Share & Trends Report

Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025

  • Report ID: GVR-2-68038-791-9
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
               1.1 Information Procurement
               1.2 Data Analysis
Chapter 2 Executive Summary
               2.1 Market Snapshot
Chapter 3 Nutrigenomics Market Variables, Trends& Scope
               3.1 Market segmentation& scope
                   3.1.1 Market Driver Analysis
                       3.1.1.1 Increasing prevalence of obesity
                       3.1.1.2 Increasing popularity for personalized diet
                       3.1.1.3 Intense research for cancer prevention and cure
                   3.1.2 Market Restraint Analysis
                       3.1.2.1 Lack of regulatory approvals
                       3.1.2.2 Lack of proven results for nutrigenomics study support
               3.2 Penetration & growth prospect mapping
               3.3 Nutrigenomics – SWOT Analysis, By Factor (political & legal, economic and technological)
               3.4 Industry Analysis – Porter’s
Chapter 4 Nutrigenomics: Application Scope Estimates & Trend Analysis
               4.1 Nutrigenomics market: application scope movement analysis
               4.2 Obesity
                   4.2.1 Obesity Discovery market, 2014 - 2025 (USD Million)
               4.3 Cardiovascular Diseases
                   4.3.1 Cardiovascular Diseases, 2014 - 2025 (USD Million)
               4.4 Cancer research
                   4.4.1 Cancer research market, 2014 - 2025 (USD Million)
Chapter 5 Nutrigenomics: Regional Estimates & Trend Analysis, by Technique, Application, Indication Scope
               5.1 Nutrigenomics market share by region, 2016 & 2025
               5.2 North America
                   5.2.1 North America Nutrigenomics market, 2014-2025, (USD Million)
                   5.2.2 U.S.
                       5.2.2.1 U.S. Nutrigenomics market, 2014-2025, (USD Million)
                   5.2.3 Canada
                       5.2.3.1 Canada Nutrigenomics market, 2014-2025, (USD Million)
               5.3 Europe
                   5.3.1 Europe Nutrigenomics market, 2014-2025, (USD Million)
                   5.3.2 Germany
                       5.3.2.1 Germany Nutrigenomics market, 2014-2025, (USD Million)
                   5.3.3 U.K.
                       5.3.3.1 U.K. Nutrigenomics market, 2014-2025, (USD Million)
               5.4 Asia Pacific
                   5.4.1 Asia Pacific Nutrigenomics market, 2014-2025, (USD Million)
                   5.4.2 China
                       5.4.2.1 China Nutrigenomics market, 2014-2025, (USD Million)
                   5.4.3 Japan
                       5.4.3.1 Japan Nutrigenomics market, 2014-2025, (USD Million)
               5.5 Latin America
                   5.5.1 Latin America Nutrigenomics market, 2014-2025, (USD Million)
                   5.5.2 Brazil
                       5.5.2.1 Brazil Nutrigenomics market, 2014-2025, (USD Million)
               5.6 Middle East and Africa
                   5.6.1 Middle East and Africa Nutrigenomics market, 2014-2025, (USD Million)
                   5.6.2 South Africa
                       5.6.2.1 South Africa Nutrigenomics market, 2014-2025, (USD Million)
Chapter 6 Competitive Landscape
               6.1 Strategy framework
               6.2 Market participation categorization
                   6.2.1 Royal DSM
                       6.2.1.1 Company overview
                       6.2.1.2 Financial performance
                       6.2.1.3 Technique benchmarking
                       6.2.1.4 Strategic initiatives
                   6.2.2 BASF
                       6.2.2.1 Company overview
                       6.2.2.2 Financial performance
                       6.2.2.3 Technique benchmarking
                       6.2.2.4 Strategic initiatives
                   6.2.3 Danone
                       6.2.3.1 Company overview
                       6.2.3.2 Financial performance
                       6.2.3.3 Technique benchmarking
                       6.2.3.4 Strategic initiatives
                   6.2.4 GeneSmart
                       6.2.4.1 overview
                       6.2.4.2 Financial performance
                       6.2.4.3 Technique benchmarking
                       6.2.4.4 Strategic initiatives
                   6.2.5 Unilever
                       6.2.5.1 overview
                       6.2.5.2 Financial performance
                       6.2.5.3 Technique benchmarking
                       6.2.5.4 Strategic initiatives
                   6.2.6 Genova Diagnostics
                       6.2.6.1 Company overview
                       6.2.6.2 Financial performance
                       6.2.6.3 Technique benchmarking
                       6.2.6.4 Strategic initiatives
                   6.2.7 Nutrigenomix, Inc,
                       6.2.7.1 Company overview
                       6.2.7.2 Financial performance
                       6.2.7.3 Technique benchmarking
                       6.2.7.4 Strategic initiatives
                   6.2.8 Metagenics
                       6.2.8.1 Company overview
                       6.2.8.2 Financial performance
                       6.2.8.3 Technique benchmarking
                       6.2.8.4 Strategic initiatives
                   6.2.9 Cell Logic
                       6.2.9.1 Company overview
                       6.2.9.2 Financial performance
                       6.2.9.3 Technique benchmarking
                       6.2.9.4 Strategic initiatives
                   6.2.10 WellGen
                       6.2.10.1 Company overview
                       6.2.10.2 Financial performance
                       6.2.10.3 Technique benchmarking
                       6.2.10.4 Strategic initiatives


List of Tables

TABLE 1 North America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 2 U.S. Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 3 Canada Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 4 Europe Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 5 Germany Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 6 U.K Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 7 Asia Pacific Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 8 China Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 9 Japan Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 10 Latin America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 11 Brazil Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 12 Middle East and Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 13 South Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restrain relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Nutrigenomics market application scope outlook: Key takeaways
FIG. 16 Nutrigenomics market: application scope market: movement analysis
FIG. 17 Global Obesity discovery market, 2014 - 2025 (USD Million)
FIG. 18 Global Cardiovascular Diseases, 2014 - 2025 (USD Million)
FIG. 19 Global Cancer research market, 2014 - 2025 (USD Million)
FIG. 20 Regional market place: Key takeaways
FIG. 21 Regional outlook, 2017 & 2025
FIG. 22 Strategy framework
FIG. 23 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon